Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alström Syndrome”

5 trials

Showing 5 of 5 results

Testing effectiveness (Phase 2)Study completedNCT02739217
What this trial is testing

Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome

Who this might be right for
Inflammation and FibrosisDiabetes
Liminal BioSciences Ltd. 12
Large-scale testing (Phase 3)Study completedNCT03746522
What this trial is testing

Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity

Who this might be right for
Bardet Biedl Syndrome (BBS)Alström Syndrome (AS)
Rhythm Pharmaceuticals, Inc. 52
Not applicableEnded earlyNCT02890550
What this trial is testing

Clinical Study of a Single Ciliopathy: Alström Syndrome

Who this might be right for
Alström Syndrome (ALMS)
University Hospital, Strasbourg, France 75
Large-scale testing (Phase 3)Ended earlyNCT03184584
What this trial is testing

Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome

Who this might be right for
Alström Syndrome
Liminal BioSciences Ltd. 10
Not applicableLooking for participantsNCT04461444
What this trial is testing

COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study

Who this might be right for
Bardet-Biedl SyndromeAlström Syndrome
University Hospital, Strasbourg, France 350

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation